Sphera, a leading global provider of Environmental, Social and Governance (ESG) performance and risk management software, data and consulting services, announced that long-standing customer...
Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the PD-1 inhibitor Libtayo (cemiplimab-rwlc) in combination with platinum-based chemotherapy...
GL CHEMTEC, a specialist in advanced chemistry R&D and scale-up services to support Active Pharmaceutical Ingredient (“API”) development, and the development of advanced materials...
Azenta, Inc. and the Government of Luxembourg today announced the signing of a Memorandum of Understanding ("MoU") to facilitate continued healthcare technology development in...
ProciseDx Inc. announces FDA clearance of its ProciseDx instrument and C reactive Protein (CRP) test. Procise CRP gives quantitative determination of CRP levels in...
